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Phagocytes recognize apoptotic cells using cell surface receptors, and subsequently engulf these
cells. In a recent issue ofNature, two papers reported the identification of novel phagocytic receptors
that directly interact with apoptotic cell surface phosphatidylserine (PS). The studies provide new
insights into the apoptotic cell clearance process and implicate PS receptors in additional signaling
events.Phagocytic removal is a common fate
for the large number of cells undergo-
ing apoptosis in metazoans. In mam-
mals, macrophages, the ‘‘professional
phagocytes,’’ and other ‘‘nonprofes-
sional’’ phagocytes swiftly internalize
apoptotic cells before they release
any harmful contents, and actively
suppress inflammation during the
process (Erwig and Henson, 2007).
The phagocytosis of apoptotic cells
also facilitates tissue remodeling and
viral antigen presentation. Inefficient
removal of apoptotic cells results in
chronic inflammation and autoimmune
diseases (Hanayama et al., 2006; Erwig
and Henson, 2007). The phagocytic
removal of other types of unwanted
cells or cellular components, such as
necrotic cells, nuclei expelled from ery-
throid precursor cells during erythro-
poiesis, and degenerative axons, are
also important for animal development
and health (Yoshida et al., 2005; Hoop-
fer et al., 2006; Krysko et al., 2006).
Distinguishing dying cells from living
cells is the first step toward proper
removal of apoptotic cells. Multiple
apoptotic-cell surface molecules
have been implicated as the ‘‘eat me’’
signals that attract phagocytes.
Among them, the best characterized
is phosphatidylserine (PS), a phospho-
lipid that is translocated from the inner
to the outer leaflet of the plasma mem-
brane at the early phase of apoptosis
(Erwig and Henson, 2007). Several
phagocytic receptors are attracted to
PS through indirect interactions medi-
ated by bridging molecules. For exam-
ple, integrins (avb3 and avb5) and the
Mer receptor tyrosine kinase recog-nize apoptotic cells through associa-
tion with secreted PS-binding proteins
MFG-E8 and Gas6 (respectively),
coated on apoptotic cell surfaces
(Erwig and Henson, 2007). On the
other hand, whether there exist phago-
cytic receptors that directly interact
with PS has remained elusive. The PS
receptor (PSR) and several mamma-
lian scavenger receptors were re-
ported to be such receptors, but with-
out concrete in vivo evidence, such
a role for these proteins is still in limbo
(Erwig and Henson, 2007). Indeed,
recent studies indicate that PSR may
not act in the engulfment of apoptotic
cells (Krieser et al., 2007 and refer-
ences therein).
Two papers published recently in
Nature identified Tim4 (T-cell immuno-
globulin- and mucin-domain-contain-
ing molecule) and BAI1 (brain-specific
angiogenesis inhibitor 1) as novel
PS-binding phagocytic receptors for
apoptotic cells (Miyanishi et al., 2007;
Park et al., 2007). Tim4 was identified
in a screen for engulfment-blocking
monoclonal antibodies raised against
naive peritoneal macrophages (Miya-
nishi et al., 2007). Tim4 is an antigen
of Kat5-18, one such antibody. Mean-
while, BAI1 was identified as an inter-
acting partner of engulfment-promot-
ing protein ELMO, which associates
and acts with Dock180 as a bipartite
guanine nucleotide exchange factor
for the small GTPase Rac (Gumienny
et al., 2001; Park et al., 2007). The
GTP-bound, activated Rac subse-
quently promotes cytoskeletal reorga-
nization during the engulfment of
apoptotic cells.Developmental Cell 13, DThe extracellular immunoglobulin
(IgV) domain of Tim4, a type 1 trans-
membrane protein, directly binds PS
as well as the surface of apoptotic cells
(Miyanishi et al., 2007). BAI1 is a
seven-pass transmembrane protein
with no known ligands belonging to
the adhesion-type G protein-coupled
receptor (GPCR) family (Nishimori
et al., 1997). Its extracellular domain
contains five tandem copies of throm-
bospondin type 1 repeats (TSRs),
which specifically interact with PS
(Park et al., 2007). The stable expres-
sion of Tim4 or BAI1 individually in
nonphagocytic fibroblasts promoted
these cells to specifically engulf ap-
optotic cells, suggesting that Tim4
and BAI1 recognize PS on the surface
of apoptotic cells as an eat me signal
and initiate engulfment in response to
this signal.
The injection of antibody Kat5-18
into mice peritoneum reduced the
efficiency of macrophage engulfment
of apoptotic cells and resulted in the
development of autoimmunity, indicat-
ing that Tim4 functions in vivo to
ensure efficient engulfment of apopto-
tic cells (Miyanishi et al., 2007). The
mouse Tim family has eight members
(Tim1–8). Tim1, like Tim4, also specifi-
cally interacts with PS and promotes
the engulfment of apoptotic cells
when expressed in a fibroblast cell
line (Miyanishi et al., 2007). Whether
Tim1 acts as a PS receptor awaits
in vivo demonstration.
Soluble TSRs from BAI1 inhibited
macrophage engulfment of apoptotic
thymocytes both ex vivo and in vivo.
Moreover, siRNA knockdown of BAI1ecember 2007 ª2007 Elsevier Inc. 759
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Previewsin primary mouse astrocytes reduced
engulfment efficiency (Park et al.,
2007). Together, these results estab-
lish that BAI1 promotes the engulfment
of apoptotic cells through direct inter-
action with apoptotic-cell surface PS.
The intracellular domain of BAI1 inter-
acts with the membrane-targeting
domain of ELMO1. In addition, the
engulfment activity of BAI1 is depen-
dent on the functions of ELMO and
Dock180, and is correlated with strong
activation of Rac, suggesting that the
Rac-GEF complex acts downstream
of BAI1 to mediate engulfment (Park
et al., 2007).
The findings of Miyanishi et al. (2007)
and Park et al. (2007) establish that
Tim4 and BAI1, and possibly Tim1,
directly bind PS, and act as phagocytic
receptors for apoptotic cells. These
discoveries further highlight the com-
plexity in the regulation of apoptotic
cell removal within animal bodies.
Why are multiple phagocytic receptors
responding to one eat me signal—PS?
One possible explanation is that differ-
ent receptors are required for different
aspects of engulfment. BAI1, for exam-
ple, appears to act in both the recogni-
tion and internalization of apoptotic
cells (Park et al., 2007). Second, coop-
eration among multiple low-affinity
receptors may ensure rapid uptake of
apoptotic cells. On the other hand,
the differential expression patterns of
Tim4 and MFG-E8 suggest tissue-
specific requirements. Tim4 is strongly
expressed in resident peritoneal mac-
rophages, where MFG-E8 expression
is hardly detectable, while MFG-E8 is
strongly expressed in thioglycollate-
elicited macrophages. Thus, apoptotic760 Developmental Cell 13, December 20cells may be recognized by Tim4 or
MFG-E8, depending on which type of
phagocytes they encounter (Miyanishi
et al., 2007).
The findings also raise some ques-
tions regarding the molecular mecha-
nisms governing the engulfment of
apoptotic cells. For instance, the
newly identified PS-binding activities
of the IgV domain and TSR motifs sug-
gest that other proteins bearing these
domains may possess PS-binding
ability. In addition, the fact that BAI1
is a member of the GPCR family hints
at the possible existence of a G protein
or proteins downstream of BAI1. The
characterization of Tim4 and Tim1
suggests additional functions related
to mammalian exosomes, secreted
small membrane vesicles of endocytic
origin that expose PS on their sur-
faces. Exosomes are implicated in an-
tigen presentation, cell-cell signaling,
and cell-cell interactions (Thery et al.,
2002). Tim4- or Tim1-expressing cells
retained exosomes on their surfaces
through their PS-binding activities;
moreover, exosomes facilitated the
homophilic and heterophilic interac-
tions between Tim1 and Tim4 (Miya-
nishi et al., 2007). Miyanishi et al.
(2007) proposed that Tim1 and Tim4
might promote cell-cell signaling or
cell-cell interaction, or both, via exo-
somes — novel functions for PSRs.
It would be interesting to determine
whether those exosomes on phago-
cyte surfaces interfere with or facilitate
the recognition of apoptotic cells.
Previous studies indicate additional
functions and disease relationships
for Tim4, Tim1, and BAI1 (Miyanishi
et al., 2007; Park et al., 2007 and refer-07 ª2007 Elsevier Inc.ence therein). Further studies of the
PSR activity of these proteins would
help us understand the complex role
of each protein in multiple biological
processes, and tumorigenesis and
autoimmunity in particular.
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